Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy

Background: Guidelines recommend combined therapy of glucocorticoid and cyclophosphamide (CYC) for patients with idiopathic membranous nephropathy (IMN), while it is associated with severe adverse effects. We conducted a retrospective study to evaluate the effectiveness and safety of glucocorticoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Honghong, Jiang, Fang, Xu, Gaosi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711082/
https://www.ncbi.nlm.nih.gov/pubmed/31354007
http://dx.doi.org/10.1080/0886022X.2019.1637758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711082/
https://www.ncbi.nlm.nih.gov/pubmed/31354007
http://dx.doi.org/10.1080/0886022X.2019.1637758

Ejemplares similares